These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 24767830)

  • 1. Successful treatment of juvenile xanthogranuloma using bevacizumab.
    Ashkenazy N; Henry CR; Abbey AM; McKeown CA; Berrocal AM; Murray TG
    J AAPOS; 2014 Jun; 18(3):295-7. PubMed ID: 24767830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography characteristics of epi-iridic membrane in a child with recurrent hyphema and presumed juvenile xanthogranuloma.
    Manjandavida FP; Arepalli S; Tarlan B; Shields CL
    J AAPOS; 2014 Feb; 18(1):93-5. PubMed ID: 24568997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined therapy with intravitreal bevacizumab and posterior subtenon triamcinolone acetonide injection in diabetic macular oedema.
    Kim HD; Kang KD; Choi KS; Rhee MR; Lee SJ
    Acta Ophthalmol; 2014 Nov; 92(7):e589-90. PubMed ID: 24866832
    [No Abstract]   [Full Text] [Related]  

  • 4. Benefit from bevacizumab for macular edema in central retinal vein occlusion: twelve-month results of a prospective, randomized study.
    Epstein DL; Algvere PV; von Wendt G; Seregard S; Kvanta A
    Ophthalmology; 2012 Dec; 119(12):2587-91. PubMed ID: 22902212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Juvenile Xanthogranuloma Involving the Eye and Ocular Adnexa: Tumor Control, Visual Outcomes, and Globe Salvage in 30 Patients.
    Samara WA; Khoo CT; Say EA; Saktanasate J; Eagle RC; Shields JA; Shields CL
    Ophthalmology; 2015 Oct; 122(10):2130-8. PubMed ID: 26189188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Subconjunctival steroid in the management of uveal juvenile xanthogranuloma: a case report.
    Treacy KW; Letson RD; Summers CG
    J Pediatr Ophthalmol Strabismus; 1990; 27(3):126-8. PubMed ID: 2114475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Three-year visual outcome of photodynamic therapy plus intravitreal bevacizumab with or without subtenon triamcinolone acetonide injections for polypoidal choroidal vasculopathy.
    Sakai T; Ohkuma Y; Kohno H; Hayashi T; Watanabe A; Tsuneoka H
    Br J Ophthalmol; 2014 Dec; 98(12):1642-8. PubMed ID: 25053762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of combination therapy with bevacizumab and dexamethasone intravitreal implant in patients with retinal vein occlusion.
    Singer MA; Bell DJ; Woods P; Pollard J; Boord T; Herro A; Porbandarwalla S
    Retina; 2012 Jul; 32(7):1289-94. PubMed ID: 22466480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravitreal bevacizumab for the treatment of choroidal metastasis.
    Kim M; Kim CH; Koh HJ; Lee SC; Kim SS
    Acta Ophthalmol; 2014 Feb; 92(1):e80-2. PubMed ID: 24165227
    [No Abstract]   [Full Text] [Related]  

  • 10. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glaucoma in juvenile xanthogranuloma.
    Vendal Z; Walton D; Chen T
    Semin Ophthalmol; 2006; 21(3):191-4. PubMed ID: 16912017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Moment of cyst eruption captured by optical coherence tomography in diabetic macular edema.
    Oh JH; Oh J
    Retina; 2015 Jun; 35(6):1283-4. PubMed ID: 25621946
    [No Abstract]   [Full Text] [Related]  

  • 13. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal triamcinolone acetonide versus combined intravitreal bevacizumab and dexamethasone in diffuse diabetic macular oedema.
    Sheth S; Rush R; Natarajan S; Gillies M
    Clin Exp Ophthalmol; 2011; 39(7):673-81. PubMed ID: 22452685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of ocular metastasis with anti-VEGF: a literature review and case report.
    Augustine H; Munro M; Adatia F; Webster M; Fielden M
    Can J Ophthalmol; 2014 Oct; 49(5):458-63. PubMed ID: 25284103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete resolution of iris juvenile xanthogranuloma in an infant with topical corticosteroid treatment only.
    Winter AW; Lyons CJ
    Can J Ophthalmol; 2022 Feb; 57(1):e10-e11. PubMed ID: 34077746
    [No Abstract]   [Full Text] [Related]  

  • 17. Intravitreal bevacizumab for retinal capillary hemangioblastoma: A case series and literature review.
    Slim E; Antoun J; Kourie HR; Schakkal A; Cherfan G
    Can J Ophthalmol; 2014 Oct; 49(5):450-7. PubMed ID: 25284102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor and intravitreal anti-VEGF therapy with bevacizumab in vasoproliferative retinal tumors.
    Saito W; Kase S; Fujiya A; Dong Z; Noda K; Ishida S
    Retina; 2013 Oct; 33(9):1959-67. PubMed ID: 23652580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescein angiography of iris juvenile xanthogranuloma.
    Danzig CJ; Shields CL; Mashayekhi A; Ehya H; Manquez ME; Shields JA
    J Pediatr Ophthalmol Strabismus; 2008; 45(2):110-2. PubMed ID: 18404959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to aflibercept as secondary therapy in patients with persistent retinal edema due to central retinal vein occlusion initially treated with bevacizumab or ranibizumab.
    Eadie JA; Ip MS; Kulkarni AD
    Retina; 2014 Dec; 34(12):2439-43. PubMed ID: 24999721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.